NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Navidea Biopharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2023.
  • Navidea Biopharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$2.13M, a 57% increase year-over-year.
  • Navidea Biopharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$10.2M, a 29.8% increase year-over-year.
  • Navidea Biopharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$14.1M, a 16.5% decline from 2021.
  • Navidea Biopharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$12.1M, a 12.6% decline from 2020.
  • Navidea Biopharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$10.7M, a 2.29% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$10.2M -$2.13M +$2.82M +57% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$13M -$2.43M +$495K +16.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 -$13.5M -$2.42M +$557K +18.7% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$14.1M -$3.2M +$441K +12.1% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-27
Q3 2022 -$14.5M -$4.95M -$2.53M -104% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$12M -$2.92M -$253K -9.48% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$11.7M -$2.98M +$350K +10.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$12.1M -$3.64M -$839K -29.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 -$11.2M -$2.42M +$477K +16.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$11.7M -$2.67M -$329K -14.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$11.4M -$3.33M -$658K -24.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$10.7M -$2.8M -$28.5K -1.03% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$10.7M -$2.9M +$186K +6.02% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$10.9M -$2.34M +$332K +12.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$11.2M -$2.67M -$238K -9.77% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$11M -$2.77M -$570K -25.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-26
Q3 2019 -$10.4M -$3.08M +$637K +17.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$11M -$2.67M -$247K -10.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$10.8M -$2.43M +$65.6K +2.63% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$10.8M -$2.2M +$1.32M +37.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-18
Q3 2018 -$12.2M -$3.72M -$1.34M -56% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$10.8M -$2.43M +$2.4M +49.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$13.2M -$2.5M +$648K +20.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$13.9M -$3.52M -$281K -8.67% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-15
Q3 2017 -$13.6M -$2.39M -$1.48M -162% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$12.1M -$4.82M -$2.58M -115% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$9.54M -$3.15M +$610K +16.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$10.1M -$3.24M +$223K +6.44% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$10.4M -$910K +$4M +81.5% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-15
Q2 2016 -$14.4M -$2.24M +$1.2M +34.9% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-15
Q1 2016 -$15.6M -$3.76M +$2.87M +43.3% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-15
Q4 2015 -$18.4M -$3.46M +$1.01M +22.6% Oct 1, 2015 Dec 31, 2015 8-K 2017-12-15
Q3 2015 -$19.5M -$4.91M +$451K +8.41% Jul 1, 2015 Sep 30, 2015 8-K 2017-12-15
Q2 2015 -$19.9M -$3.44M +$5.77M +62.6% Apr 1, 2015 Jun 30, 2015 8-K 2017-12-15
Q1 2015 -$25.7M -$6.62M +$1.96M +22.8% Jan 1, 2015 Mar 31, 2015 8-K 2017-12-15
Q4 2014 -$27.6M -$4.48M +$8.58M +65.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-23
Q3 2014 -$36.2M -$5.36M +$4.56M +46% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-23
Q2 2014 -$40.8M -$9.22M -$760K -8.99% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-23
Q1 2014 -$40M -$8.58M -$1.58M -22.5% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-23
Q4 2013 -$38.4M -$13.1M -$6.03M -85.8% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$32.4M -$9.93M -$856K -9.44% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$31.6M -$8.46M -$3.07M -57% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 -$28.5M -$7M -$498K -7.65% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 -$28M -$7.03M +$2.02M +22.3% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 -$30M -$9.07M -$2.6M -40.1% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 -$27.4M -$5.39M -$1.8M -50.2% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 -$25.6M -$6.51M -$1.5M -30.1% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 -$24.1M -$9.04M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-14
Q3 2011 -$6.47M -$2.85M -78.9% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$3.59M -$2.66M -286% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$5M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 -$3.62M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 -$929K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.